DOI QR코드

DOI QR Code

Characteristics of Respiratory Syncytial Virus Infection in Hospitalized Children Before and During the COVID-19 Pandemic in Thailand

  • Wilawan Chaiut (Department of Community Medicine, Faculty of Medicine, Chiang Mai University) ;
  • Ratana Sapbamrer (Department of Community Medicine, Faculty of Medicine, Chiang Mai University) ;
  • Sauwaluk Dacha (Department of Physical Therapy, Faculty of Associated Medical Science, Chiang Mai University) ;
  • Tavitiya Sudjaritruk (Division of Infectious Diseases, Department of Pediatrics, Faculty of Medicine, Chiang Mai University) ;
  • Ida Parwati (Department of Clinical Pathology, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin General Hospital) ;
  • Anton Sumarpo (Department of Clinical Pathology, Faculty of Medicine, Universitas Padjadjaran/Hasan Sadikin General Hospital) ;
  • Rungnapa Malasao (Department of Community Medicine, Faculty of Medicine, Chiang Mai University)
  • Received : 2023.01.10
  • Accepted : 2023.03.13
  • Published : 2023.05.31

Abstract

Objectives: This study compared the epidemiological and clinical manifestations of patients hospitalized with respiratory syncytial virus (RSV) infection before and during the coronavirus disease 2019 (COVID-19) pandemic at a tertiary care hospital in Chiang Mai Province, Thailand. Methods: This retrospective observational study utilized data from all cases of laboratory-confirmed RSV infection at Maharaj Nakorn Chiang Mai Hospital from January 2016 to December 2021. Differences in the clinical presentation of RSV infection before (2016 to 2019) and during (2020 to 2021) the COVID-19 pandemic were analyzed and compared. Results: In total, 358 patients hospitalized with RSV infections were reported from January 2016 to December 2021. During the COVID-19 pandemic, only 74 cases of hospitalized RSV infection were reported. Compared to pre-pandemic levels, the clinical presentations of RSV infection showed statistically significant decreases in fever on admission (p=0.004), productive cough (p=0.004), sputum (p=0.003), nausea (p=0.03), cyanosis (p=0.004), pallor (p<0.001), diarrhea (p<0.001), and chest pain (p<0.001). Furthermore, vigilant measures to prevent the spread of COVID-19, including lockdowns, also interrupted the RSV season in Thailand from 2020 to 2021. Conclusions: The incidence of RSV infection was affected by the COVID-19 pandemic in Chiang Mai Province, Thailand, which also changed the clinical presentation and seasonal pattern of RSV infection in children.

Keywords

Acknowledgement

We would like to thank the Medical Records and Statistics Section of Maharaj Nakorn Chiang Mai Hospital, for their important cooperation in establishing the pediatric preparedness register. The funding sources did not influence the study design, the collection or interpretation of data, the preparation or approval of the manuscript, or the decision to submit the manuscript for publication.

References

  1. Fry AM, Chittaganpitch M, Baggett HC, Peret TC, Dare RK, Sawatwong P, et al. The burden of hospitalized lower respiratory tract infection due to respiratory syncytial virus in rural Thailand. PLoS One 2010;5(11):e15098.
  2. Pastula ST, Hackett J, Coalson J, Jiang X, Villafana T, Ambrose C, et al. Hospitalizations for respiratory syncytial virus among adults in the United States, 1997-2012. Open Forum Infect Dis 2017;4(1):ofw270.
  3. Horthongkham N, Athipanyasilp N, Sirijatuphat R, Assanasen S, Sutthent R. Prevalence and molecular characterization of human metapneumovirus in influenza a negative sample in Thailand. J Clin Lab Anal 2014;28(5):398-404. https://doi.org/10.1002/jcla.21700
  4. Piralam B, Tomczyk SM, Rhodes JC, Thamthitiwat S, Gregory CJ, Olsen SJ, et al. Incidence of pneumococcal pneumonia among adults in rural Thailand, 2006-2011: implications for pneumococcal vaccine considerations. Am J Trop Med Hyg 2015;93(6):1140-1147. https://doi.org/10.4269/ajtmh.15-0429
  5. Aikphaibul P, Theerawit T, Sophonphan J, Wacharachaisurapol N, Jitrungruengnij N, Puthanakit T. Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand. Influenza Other Respir Viruses 2021;15(1):64-71. https://doi.org/10.1111/irv.12793
  6. Naorat S, Chittaganpitch M, Thamthitiwat S, Henchaichon S, Sawatwong P, Srisaengchai P, et al. Hospitalizations for acute lower respiratory tract infection due to respiratory syncytial virus in Thailand, 2008-2011. J Infect Dis 2013;208 Suppl 3:S238-S245. https://doi.org/10.1093/infdis/jit456
  7. Praphasiri P, Shrestha M, Patumanond J, Nakphook S, Chawalchitiporn S, Ditsungnoen D, et al. Underlying cardiopulmonary conditions as a risk factor for influenza and respiratory syncytial virus infection among community-dwelling adults aged ≥65 years in Thailand: findings from a two-year prospective cohort study. Influenza Other Respir Viruses 2021;15(5):634-640. https://doi.org/10.1111/irv.12855
  8. Fry AM, Lu X, Chittaganpitch M, Peret T, Fischer J, Dowell SF, et al. Human bocavirus: a novel parvovirus epidemiologically associated with pneumonia requiring hospitalization in Thailand. J Infect Dis 2007;195(7):1038-1045. https://doi.org/10.1086/512163
  9. Delestrain C, Danis K, Hau I, Behillil S, Billard MN, Krajten L, et al. Impact of COVID-19 social distancing on viral infection in France: a delayed outbreak of RSV. Pediatr Pulmonol 2021;56(12):3669-3673. https://doi.org/10.1002/ppul.25644
  10. Di Mattia G, Nenna R, Mancino E, Rizzo V, Pierangeli A, Villani A, et al. During the COVID-19 pandemic where has respiratory syncytial virus gone? Pediatr Pulmonol 2021;56(10):3106-3109. https://doi.org/10.1002/ppul.25582
  11. Kaewpan W, Rojpaisarnkit K, Pengpid S, Peltzer K. Factors affecting face mask-wearing behaviors to prevent COVID-19 among Thai people: a binary logistic regression model. Front Psychol 2022;13:996189.
  12. Ali ST, Lau YC, Shan S, Ryu S, Du Z, Wang L, et al. Prediction of upcoming global infection burden of influenza seasons after relaxation of public health and social measures during the COVID-19 pandemic: a modelling study. Lancet Glob Health 2022;10(11):e1612-e1622. https://doi.org/10.1016/S2214-109X(22)00358-8
  13. Doung-Ngern P, Suphanchaimat R, Panjangampatthana A, Janekrongtham C, Ruampoom D, Daochaeng N, et al. Casecontrol study of use of personal protective measures and risk for SARS-CoV 2 infection, Thailand. Emerg Infect Dis 2020;26(11):2607-2616. https://doi.org/10.3201/eid2611.203003
  14. Xu R, Fathima P, Strunk T, de Klerk N, Snelling TL, Richmond PC, et al. RSV prophylaxis use in high-risk infants in Western Australia, 2002-2013: a record linkage cohort study. BMC Pediatr 2020;20(1):490.
  15. Qiu W, Zheng C, Huang S, Zhang Y, Chen Z. Epidemiological trend of RSV infection before and during COVID-19 pandemic: a three-year consecutive study in China. Infect Drug Resist 2022;15:6829-6837. https://doi.org/10.2147/IDR.S388231
  16. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383. https://doi.org/10.1016/0021-9681(87)90171-8
  17. Althouse BM, Flasche S, Minh LN, Thiem VD, Hashizume M, Ariyoshi K, et al. Seasonality of respiratory viruses causing hospitalizations for acute respiratory infections in children in Nha Trang, Vietnam. Int J Infect Dis 2018;75:18-25. https://doi.org/10.1016/j.ijid.2018.08.001
  18. Dotan M, Ashkenazi-Hoffnung L, Samra Z, Livni G, Yarden-Bilavsky H, Amir J, et al. Hospitalization for respiratory syncytial virus bronchiolitis and disease severity in twins. Isr Med Assoc J 2013;15(11):701-704.
  19. Fanos V, Scarcella A, Puddu M, Gallini F, Tuminelli F, Bragetti P, et al. Respiratory disorders and hospitalization rates during the second RSV season in preterm infants who received palivizumab prophylaxis during their first RSV season. J Chemother 2009;21(3):302-310. https://doi.org/10.1179/joc.2009.21.3.302
  20. Sinaei R, Pezeshki S, Parvaresh S, Sinaei R. Why COVID-19 is less frequent and severe in children: a narrative review. World J Pediatr 2021;17(1):10-20. https://doi.org/10.1007/s12519-020-00392-y
  21. Uppala R, Sitthikarnkha P, Niamsanit S, Sutra S, Thepsuthammarat K, Techasatian L, et al. Effect of the COVID-19 pandemic on lower respiratory tract infection determinants in Thai hospitalized children: national data analysis 2015-2020. Trop Med Infect Dis 2022;7(8):151.
  22. Foley DA, Yeoh DK, Minney-Smith CA, Martin AC, Mace AO, Sikazwe CT, et al. The interseasonal resurgence of respiratory syncytial virus in Australian children following the reduction of coronavirus disease 2019-related public health measures. Clin Infect Dis 2021;73(9):e2829-e2830. https://doi.org/10.1093/cid/ciaa1906
  23. Thongpan I, Suntronwong N, Vichaiwattana P, Wanlapakorn N, Vongpunsawad S, Poovorawan Y. Respiratory syncytial virus, human metapneumovirus, and influenza virus infection in Bangkok, 2016-2017. PeerJ 2019;7:e6748.
  24. Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect 2020;81(2):266-275. https://doi.org/10.1016/j.jinf.2020.05.046
  25. Kuitunen I, Artama M, Makela L, Backman K, Heiskanen-Kosma T, Renko M. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in Finland during early 2020. Pediatr Infect Dis J 2020;39(12):e423-e427. https://doi.org/10.1097/INF.0000000000002845
  26. Chan HC, Tambyah PA, Tee NW, Somani J. Return of other respiratory viruses despite the disappearance of influenza during COVID-19 control measures in Singapore. J Clin Virol 2021;144:104992.
  27. Huppertz HI, Kopp MV, Hubner J. Prevention of infections by influenza virus and respiratory syncytial virus after removal of the lockdown measures. Monatsschr Kinderheilkd 2021;169(11): 1072-1074 (German). https://doi.org/10.1007/s00112-021-01278-7
  28. Ryu S, Han C, Ali ST. Achangwa C, Yang B, Pei S. Impact of public health and social measures on hand-foot-mouth disease transmission and prediction of upcoming season after relaxation of COVID-19 control measures. Res Sq [Preprint]. 2022 [cited 2023 Feb 21]. Available from: https://doi.org/10.21203/rs.3.rs-1999622/v1.
  29. Chuaychoo B, Rattanasaengloet K, Banlengchit R, Horthongkham N, Athipanyasilp N, Totanarungroj K, et al. Characteristics, complications, and mortality of respiratory syncytial virus compared with influenza infections in hospitalized adult patients in Thailand. Int J Infect Dis 2021;110:237-246. https://doi.org/10.1016/j.ijid.2021.07.045
  30. Chuaychoo B, Ngamwongwan S, Kaewnaphan B, Athipanyasilp N, Horthongkham N, Kantakamalakul W, et al. Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. J Clin Virol 2019;117:103-108. https://doi.org/10.1016/j.jcv.2019.07.001
  31. Niyatiwatchanchai N, Deesomchok A, Chaiwong W, Duangjit P, Pothirat C, Liwsrisakun C, et al. Comparative study of early impacts of post-COVID-19 pneumonia on clinical manifestations, pulmonary function, and chest radiographs. Medicina (Kaunas) 2022;58(2):216.
  32. Aikphaibul P, Theerawit T, Sophonphan J, Wacharachaisurapol N, Jitrungruengnij N, Puthanakit T. Risk factors of severe hospitalized respiratory syncytial virus infection in tertiary care center in Thailand. Influenza Other Respir Viruses 2021;15(1):64-71. https://doi.org/10.1111/irv.12793
  33. Ozeki S, Kawada JI, Yamashita D, Yasufuku C, Akano T, Kato M, et al. Impact of the coronavirus disease 2019 pandemic on the clinical features of pediatric respiratory syncytial virus infection in Japan. Open Forum Infect Dis 2022;9(11):ofac562.
  34. Xie Z. Pay attention to SARS-CoV-2 infection in children. Pediatr Investig 2020;4(1):1-4. https://doi.org/10.1002/ped4.12178
  35. Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med 2020;383(4):347-358. https://doi.org/10.1056/NEJMoa2021756
  36. Ryu S, Hwang Y, Ali ST, Kim DS, Klein EY, Lau EH, et al. Decreased use of broad-spectrum antibiotics during the coronavirus disease 2019 epidemic in South Korea. J Infect Dis 2021;224(6):949-955. https://doi.org/10.1093/infdis/jiab208